Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAge Labs (BIOA) Change in Account Payables (2024 - 2025)

BioAge Labs (BIOA) has disclosed Change in Account Payables for 2 consecutive years, with -$2.3 million as the latest value for Q4 2025.

  • Quarterly Change in Account Payables fell 1730.95% to -$2.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $788000.0 through Dec 2025, up 13033.33% year-over-year, with the annual reading at $788000.0 for FY2025, 13033.33% up from the prior year.
  • Change in Account Payables hit -$2.3 million in Q4 2025 for BioAge Labs, down from $3.6 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $3.6 million in Q3 2025 to a low of -$2.6 million in Q2 2025.